Physician

James P.a. Yhip, M.D.

According to 2025 Medicare claims, James Yhip, M.D. (NPI: 1013949601) practices interventional cardiology in the Amarillo, TX market, with the plurality of this provider's patient population coming from Potter, TX. This provider's primary affiliated billing organization is AMARILLO HEART INSTITUTE, LLP (NPI: 1295448710; TIN: 883862154) and primary practice location at 79124-2193. Yhip is affiliated with the Texoma Clinical Partners ACO, LLC (ACO ID: A4585), Caravan Health ACO 43 LLC (ACO ID: A4974), Main Street Rural Health Magnolia ACO LLC (ACO ID: A5400), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Yhip's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,957 traditional Medicare patients, billed 6,481 HCPCS/CPT codes, and received $813,910 in Medicare payments. The top billing code was 78431 (Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan). Part D data shows 3,547 prescription claims across 402 beneficiaries totaling $340,825 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 23 claims. Open Payments data shows 60 records totaling $1,977. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $35,694 to $12,999.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	3,220	10,509	$758,481
2016	3,430	10,944	$785,613
2017	3,396	10,738	$781,529
2018	3,584	10,098	$679,245
2019	3,576	10,066	$703,614
2020	3,420	10,149	$695,634
2021	3,307	8,976	$620,470
2022	1,907	5,297	$292,099
2023	1,740	6,086	$553,019
2024	1,957	6,481	$813,910

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	342	1,390	$114,265
2016	484	2,039	$250,887
2017	614	3,423	$388,476
2018	699	4,144	$437,602
2019	686	4,542	$515,704
2020	725	5,040	$601,136
2021	761	5,756	$745,478
2022	612	3,036	$376,307
2023	414	3,081	$302,813
2024	402	3,547	$340,825

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	105	345	$30,659
2016	56	292	$15,854
2017	40	214	$7,431
2018	38	141	$4,621
2019	N/R	49	$2,452
2020	N/R	119	$5,636
2021	N/R	18	$1,698
2022	N/R	23	$2,232
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78431	Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan	214	214	$1,759
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	445	446	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	259	709	$90
J2785	Injection, regadenoson, 0.1 mg	247	988	$6
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	737	943	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	70	5,310	$100,521
Xarelto	Rivaroxaban	58	3,180	$60,039
Entresto	Sacubitril/Valsartan	26	1,665	$36,717
Jardiance	Empagliflozin	25	1,290	$24,101
Multaq	Dronedarone Hcl	16	1,020	$21,135

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	60	$1,977	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James P.a. Yhip, M.D.?

Tedicare shows public-source Medicare data for James P.a. Yhip, M.D. (NPI 1013949601), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James P.a. Yhip, M.D. have ACO affiliation data?

James P.a. Yhip, M.D. is shown with ACO affiliation data for Texoma Clinical Partners ACO, LLC (MSSP, ACO ID A4585), Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), Main Street Rural Health Magnolia ACO LLC (MSSP, ACO ID A5400), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to James P.a. Yhip, M.D.?

James P.a. Yhip, M.D. is linked to AMARILLO HEART INSTITUTE, LLP (billing NPI 1295448710) in the available physician profile data.

Does James P.a. Yhip, M.D. have Open Payments data?

James P.a. Yhip, M.D. has 60 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.